Havana, Mar 17.- Cuba and the Islamic Republic of Iran are evaluating the efficacy, potency and safety of the drug Soberana-02, one of the five vaccine candidates against COVID-19 produced by the Caribbean island, a local source reported today.
Havana, Mar 16.- More than 400 thousand children from all over Cuba are today immunized against poliomyelitis after the recently concluded vaccination campaign to prevent this disease that causes acute flaccid paralysis in minors.
Havana, Mar 15.- The Cuban Neuroscience Society (SONECUB) recommends ten tips to face COVID-19, which has spread to 190 countries where they already amount to almost 120 million confirmed cases and more than two million 655 thousand deaths.
Havana, Mar 13.- A new clinical trial will determine the evaluation of effectiveness and safety of nasal and sublingual treatment with the drug CIGB2020, in people who have been contacts or suspected of infection by the SARS-CoV-2 coronavirus, which causes COVID-19, reported the Cuban Public Registry of Clinical Trials.
Havana, Mar 12.- On Sunday, March 14, summer time will come into effect in the Atlantic Zone, so at 12:00 p.m. on Saturday the 13th in the country the hands of the clocks must be moved forward one hour and thus the current normal will end.
Havana, Mar 11.- The Immunoassay Center of Cuba reported that the Caribbean island has a new ultramicroanalytic system, which allows detecting several diseases early, including Covid-19, the local press said today.
Belgrade, Mar 10.- The topic, Cuban vaccine candidates: a new hope against Covid-19, was the focus of an online appearance today by the Cuban ambassador to Serbia, Gustavo Tristá del Todo.
Guatemala, Mar 9.- The National Institute of Seismology, Volcanology, Meteorology and Hydrology of Guatemala (Insivumeh) confirmed pulses of increase in the eruptive activity of the Pacaya volcano.
Havana, Mar 8.- The Director of Science and Innovation of the BioCubaFarma Business Group, Rolando Pérez Rodríguez, described the beginning of the third phase of the clinical trials of the Cuban anti-COVID-19 Soberana 02 vaccine candidate as a milestone, after receiving green light by the Center for State Control of Medicines, Equipment and Medical Devices (CECMED).
Havana, Mar 6.- Phase III of the anti-COVID-19 vaccine candidate Abdala (CIGB 66) plans to include 42 thousand subjects in the provinces of Santiago de Cuba and Guantánamo, when the Center for State Control of Medicines, Equipment and Medical Devices ( CECMED ) authorizes it.